Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Defining hypoglycaemia: what level has clinical relevance?

Literature DB >> 19018507

Defining hypoglycaemia: what level has clinical relevance?

B M Frier¹.

Abstract

Mesh：

Substances：
Blood Glucose

Year: 2008 PMID： 19018507 DOI： 10.1007/s00125-008-1209-3

Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122

× No keyword cloud information.

14 in total

1. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia.

Authors: S G H A Swinnen; P Mullins; M Miller; J B L Hoekstra; F Holleman
Journal: Diabetologia Date: 2008-09-20 Impact factor: 10.122

2. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.

Authors: N S Schwartz; W E Clutter; S D Shah; P E Cryer
Journal: J Clin Invest Date: 1987-03 Impact factor: 14.808

3. Preserved counterregulatory hormone release and symptoms after short term hypoglycemic episodes in normal men.

Authors: A Peters; F Rohloff; W Kerner
Journal: J Clin Endocrinol Metab Date: 1995-10 Impact factor: 5.958

Review 4. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

Authors:
Journal: Diabetes Care Date: 2005-05 Impact factor: 19.112

5. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.

Authors: Scott A Segel; Deanna S Paramore; Philip E Cryer
Journal: Diabetes Date: 2002-03 Impact factor: 9.461

6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors: D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal: N Engl J Med Date: 1993-09-30 Impact factor: 91.245

Review 7. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

Authors: P E Cryer
Journal: Diabetologia Date: 2002-04-26 Impact factor: 10.122

8. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects.

Authors: H Vea; R Jorde; G Sager; S Vaaler; J Sundsfjord
Journal: Diabetologia Date: 1992-10 Impact factor: 10.122

9. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.

Authors: A Mitrakou; C Ryan; T Veneman; M Mokan; T Jenssen; I Kiss; J Durrant; P Cryer; J Gerich
Journal: Am J Physiol Date: 1991-01

10. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.

Authors: G Bolli; P de Feo; P Compagnucci; M G Cartechini; G Angeletti; F Santeusanio; P Brunetti; J E Gerich
Journal: Diabetes Date: 1983-02 Impact factor: 9.461

17 in total

10. Prolonged exercise in type 1 diabetes: performance of a customizable algorithm to estimate the carbohydrate supplements to minimize glycemic imbalances.

Authors: Maria Pia Francescato; Giuliana Stel; Elisabetta Stenner; Mario Geat
Journal: PLoS One Date: 2015-04-28 Impact factor: 3.240

Defining hypoglycaemia: what level has clinical relevance?

1. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia.

2. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.

3. Preserved counterregulatory hormone release and symptoms after short term hypoglycemic episodes in normal men.

Review 4. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

5. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.

6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Review 7. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.

8. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects.

9. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.

10. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.

1. Preventing hypoglycaemia: what is the appropriate glucose alert value?

2. Assessment of Glycemic Control in Nursing Home Residents with Diabetes.

3. Hypoglycaemic symptoms and hypoglycaemia threshold in older people with diabetes--a patient perspective.

Review 4. Drug-induced hypoglycaemia: an update.

5. Blood glucose levels and performance in a sports cAMP for adolescents with type 1 diabetes mellitus: a field study.

Review 6. Continuous Glucose Monitoring: Impact on Hypoglycemia.

Review 7. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

8. Peripheral glucose levels and cognitive outcome after ischemic stroke-Results from the Munich Stroke Cohort.

9. Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry.

10. Prolonged exercise in type 1 diabetes: performance of a customizable algorithm to estimate the carbohydrate supplements to minimize glycemic imbalances.